Although a key role of cross-dressing has been established in immunity to viral infection and more recently in the instigation of transplant rejection, its role in tolerance is unclear. We investigated the role of intragraft dendritic cells (DCs) and crossdressing in mouse major histocompatibility complex (MHC)-mismatched liver transplant tolerance that occurs without therapeutic immunosuppression. Although donor interstitial DCs diminished rapidly after transplantation, they were replaced in the liver by host DCs that peaked on postoperative day (POD) 7 and persisted indefinitely. Approximately 60% of these recipient DCs displayed donor MHC class I, indicating cross-dressing. By contrast, only a very minor fraction (0%-2%) of crossdressed DCs (CD-DCs) was evident in the spleen. CD-DCs sorted from liver grafts expressed much higher levels of T cell inhibitory programed death ligand 1 (PD-L1) and high levels of interleukin-10 compared with non-CD-DCs (nCD-DCs) isolated from the graft. Concomitantly, high incidences of programed death protein 1 (PD-1) hi T cell immunoglobulin and 
immunosuppression. (2) However, the mechanisms underlying liver transplant tolerance are not well understood. Better understanding of these mechanisms could have important implications for the promotion of tolerance in the clinic and reduced dependence of transplant recipients on immunosuppressive drugs. Importantly, the liver has a unique constituency of parenchymal and nonparenchymal cells that have been implicated in immune regulation and tolerance induction. (3, 4) These include resident professional and nonprofessional antigen-presenting cells (APCs), including DCs and hepatic macrophages (Kupffer cells), (5, 6) liver sinusoidal endothelial cells (LSEC), (7) hepatic stellate cells, (8) and hepatocytes. (9) Of these, DCs are uniquely well-equipped APCs that promote self-tolerance in the steady-state (10) and regulate immunity. (11) Liver-resident DCs comprise several subsets (4, 5) characterized by their immaturity, resistance to maturation, (12) and tolerogenic properties. (13) (14) (15) The predominant, conventional liver myeloid DC population has been shown to attenuate hepatic inflammation and fibrosis (16, 17) and to regulate liver warm and transplant-induced ischemia-reperfusion injury. (18, 19) Moreover, liver DCs can subvert T cell responses (5, 13, 15, 20) and prolong allograft survival. (21, 22) Molecular mechanisms whereby liver APCs regulate/ inhibit T cell responses include their expression of programed death ligand-1 (PD-L1 5 B7 homologue 1 [B7-H1]), (7, 15, 23) interleukin (IL)-10, (24) FasL, (25) the Notch ligand Jagged 1, (9) CD39, (19) and the immunoreceptor tyrosine-based activation motif-bearing transmembrane adaptor protein DNAX-activating protein of 12 kDa (DAP12). (26, 27) Of these molecules, PD-L1, IL-10, and DAP12 have been implicated in the regulation of mouse "spontaneous" liver transplant tolerance. (22) An important role of cross-dressing of host APCs has been established in immunity to viral infection, (28) and more recently in the acute rejection of murine kidney, heart, and skin grafts. (29, 30) Thus, Liu et al. (29) have shown that, in mouse heart transplantation, host DCs that acquire donor intact MHC molecules (CDDCs) play an important role in allograft rejection. MHC molecules transferred from donor DCs via extracellular vesicles were internalized or remained attached to recipient DCs and promoted their activation. This cross-dressing by host DCs may occur throughout the life span of the graft. (31) Given these observations, and because mechanisms underlying spontaneous liver allograft acceptance remain unclear, we examined the properties of graft-infiltrating CDDCs in the mouse orthotopic liver transplant model. Our data establish a role for cross-dressing in transplant tolerance and indicate that this mechanism may underlie the acceptance of hepatic allografts in the absence of immunosuppressive therapy.
Materials and Methods

STUDY DESIGN
For all (liver transplant) experiments, age-matched animals were distributed randomly into experimental groups. Liver transplants were performed in male B6 donors to male C3H recipients because for anatomic/ surgical reasons, male B6 (or B10) into male C3H is the model of choice for orthotopic allogeneic liver transplantation in the mouse. (27, (32) (33) (34) After surgery, each mouse was housed alone for the first week. All surgeries were performed during the light cycle without fasting. The number of animals (3-6 mice per time point posttransplantation) used in each analytical experiment was based on previous studies in which the orthotopic allogeneic liver transplant model was used. All experiments were conducted under an Institutional Animal Care and Use Committee-approved protocol and in accordance with criteria outlined in the Guide (35) generated initially in the 129/SvJ and B6 hybrid background, were backcrossed onto B6, and breeding pairs were kindly provided by Marco Colonna (Washington University School of Medicine, St. Louis, MO). Animals were maintained in the specific pathogen-free Central Animal Facility of the University of Pittsburgh School of Medicine. They were fed a diet of Purina rodent chow (Ralston Purina, St. Louis, MO) and received tap water ad libitum. Mice (4-5 per cage) were housed in Optimice (Animal Care Systems, Inc., Centennial, CO).
LIVER TRANSPLANTATION
Orthotopic mouse liver transplantation was performed as described previously, (34) without immunosuppressive therapy.
FLOW CYTOMETRY AND FLOW IMAGING
Cells were incubated with Zombie Aqua dye (Zombie; Biolegend, San Diego, CA) according to the manufacturer's instructions and treated with FccRblocking rat a-mouse CD16/32 antibody (Ab) (93; Biolegend). For surface staining, cells were incubated for 30 minutes at 48C with different combinations of fluorochrome-conjugated Ab specific for H-2K b (AF6-88.5), H-2D k (AF6-120.1), CD3 (PB 17A2), CD4 (H129.19), CD8a (53-6.7), CD11c (HL3), CD11b (M1/70), CD45.1 (A20), CD45.2 (104), CD44 (IM7), CD49b (DX5), CD62L (MEL-14), CD80 (16-10A1), CD86 (GL1), PD-L1 (CD274; 10F.9G2), B220/CD45R (RA3-6B2), F4/80 (BM8), NK1.1 (PK136), T cell immunoglobulin and mucin domain containing 3 (TIM-3; 8B.2C12), or programed death protein 1 (PD-1; J43) (eBioscience; BD, San Diego, CA; Biolegend). After staining, the cells were fixed in 4% vol/vol paraformaldehyde. For intracellular staining, the cells were fixed and permeabilized using Fix and Perm reagent (eBioscience), and fluorochrome-conjugated Abs specific for CTLA-4 (UC10-4B9), interferon-c (IFNc; XMG1.2), tumor necrosis factor a (TNFa; MP6-XT22), IL-2 (JES6-5H4), IL-6 (MB5-20F3), IL-10 (JES5-16E3), or IL12p40 (C17.8) (eBioscience, BD) were used. Appropriate fluorochrome-conjugated isotype-matched immunoglobulin G was used as a negative control. Before cytokine staining, the cells were cultured for 4 hours at 10 6 cells/mL in 15-mL tubes with phorbol myristate acetate (PMA; 20 ng/mL, Sigma, St. Louis, MO) and ionomycin (100 mM, Sigma). GolgiStop (0.66 ll/ml; BD) was added 30 minutes after PMA/ ionomycin addition. An Annexin-V Apoptosis Detection Kit was purchased from eBioscience and used according to the manufacturer's instructions.
All flow data were acquired on an LSR Fortessa flow cytometer (BD) and analyzed using FlowJo version 10 software (Tree Star, San Carlos, CA). Imaging cytometry cell data were acquired on an ImageStream IS100 (Amnis Corporation, San Diego, CA) and analyzed using IDEAS software (Amnis).
FLOW SORTING
Graft nonparenchymal cells were isolated on POD 7. CD11c 1 selection was performed by MACS (Miltenyi, Auburn, CA), followed by H-2K b positive and negative flow sorting (CD-DCs and non-CD-DCs [nCD-DCs]) using a BD FACSAria II.
NANOSTRING ANALYSIS
A 561-gene panel (mouse immunology panel; www. nanostring.com) including 14 housekeeping genes and six positive controls (Nanostring Technologies, Seattle, WA) was used. RNA was extracted from flow-sorted graft CD-DCs or nCD-DCs using the RNeasy Micro Kit (Qiagen, Hilden, Germany). RNA concentrations were determined by Nanodrop (Thermo Scientific, Wilmington, DE). Reporter and capture probes were hybridized during 20-hour incubation at 658C, and the resulting RNA complexes were subsequently immobilized and counted on an nCounter analyzer (Nanostring Technologies) according to the manufacturer's instructions. Raw data were normalized based on the geometric mean of negative controls, internal housekeeping genes, and positive controls in nSolver 3.0. Ingenuity Pathway Analysis (IPA) software (Qiagen) was used for pathway analysis.
CONFOCAL MICROSCOPY
After fluorescence-activated cell sorting, CD-DCs were restained with CD11c, H-2K b , and H-2D k Ab, then fixed with 4% paraformaldehyde. Confocal microscopy was performed using a Nikon A1 confocal microscope.
TWO-PHOTON INTRAVITAL MICROSCOPY
Two-photon intravital microscopy was performed on native livers of CD11c-YFP mice and on CD11c-YFP liver allografts (on POD 7 and 30). Mice were anesthetized with isoflurane and the liver was exposed after a midline abdominal incision. The left lateral lobe was pulled gently and immobilized with a custom cup for intravital imaging. Oxygen and core body temperature were maintained at 378C with a homeothermic controller (TC-1000; CWE, Ardmore, PA). Blood vessels were visualized by injecting Evans Blue stain (100 lg in PBS intravenously). Image acquisition was performed using an A1R MP Nikon system and a Ti:Sapphire Chameleon IR (Coherent) laser tuned and modelocked to 900 nm. (36) 
STATISTICAL ANALYSIS
GraphPad Prism (version 5.00; Graphpad Software Inc., San Diego, CA) was used for statistical analyses. Results are expressed as the mean 6 standard error of the mean (SEM). Multiple comparisons on a single data set were performed by 1-way analysis of variance (ANOVA), followed by Tukey-Kramer multiple comparisons test. In all experiments, P < 0.05 was considered significant.
ADDITIONAL METHODS
Details of additional methods are provided in the Supporting Information.
Results
HOST DCs CROSS-DRESSED WITH DONOR MHC MOLECULES (CD-DCs) ARE PREVALENT IN LIVER ALLOGRAFTS
To determine the source of DCs in liver allografts, we first examined the presence of donor-and recipientderived DCs in B6 (H-2 b ) grafts of C3H (H-2 k ) recipients at various time points post-transplantation (Fig.   1A ). No immunosuppressive therapy was administered; in this model, > 80% of liver grafts survive long-term (>100 days). (27, 33) DCs were defined as CD11c were the main source of cross-dressing.
To increase the sensitivity of donor cell detection, we also examined B6 yellow fluorescent protein (YFP)-CD11c liver allografts transplanted into C3H recipients by 2-photon intravital microscopy. Although some donor CD11c
1 YFP 1 cells remained in the graft on POD 7, these cells disappeared completely by POD 30 (Fig. 1D) . Thus, donor DCs disappear from mouse liver allografts rapidly and are replaced by host-derived graftinfiltrating DC, the majority of which are cross-dressed with donor MHC class I.
Other host-derived (CD45. 2 1 ) leukocytes were also cross-dressed with donor intact MHC class I molecules. As shown in Figure 1E 1 DCs, their perceived role in liver tolerance, and the prevalence of CD-DC in the graft, we focused further studies on this key immune cell population.
HEPATOCYTES ARE THE PRINCIPAL SOURCE OF DONOR MHC CLASS I EXPRESSED BY CD-DCs
To determine which hepatic parenchymal cells were the source of donor MHC class I expressed by host Gating strategy used to analyze cross-dressed CD) immune cells is shown. Liver NPCs were isolated on POD 7 after B6 WT to C3H transplantation and were analyzed by flow cytometry. Representative data from n 5 4 mice are shown. (F) Contribution of each CD immune cell type to the overall CD population. Bars represent the mean 1 SEM (n 5 4 mice). *P < 0.05; **P < 0.01; ***P < 0.001. P values were generated by 1-way ANOVA followed by Tukey-Kramer multiple comparisons test. dressed with donor MHC class I from LSECs or stellate cells. The presence of transwells markedly reduced the incidence of DCs that expressed hepatocytederived donor MHC class I, indicating that physical contact was required for cross-dressing.
CD-DCs IN LIVER ALLOGRAFTS EXPRESS HIGHER LEVELS OF PD-L1 AND IL-10 THAN nCD-DCs
Cross-dressing of host DCs has been associated recently with allograft rejection. (29, 30) However, our data show that DC cross-dressing also occurs during liver allograft tolerance. To further understand the mechanisms involved, we examined the kinetics of CD-DCs in the liver grafts and their expression of immune stimulatory/inhibitory molecules. Both the absolute number of DCs in the graft and the percentage of DCs within the graft hematopoietic cell population peaked on POD 7, then decreased over time, a pattern similar to that of CD-DCs (Fig. 3A) . Importantly, > 50% of graft DCs were cross-dressed on POD 7 and approximately 40% on POD 14, with 20% still evident on POD 300. Expression of PD-L1 was 12 times higher on CD-DCs than on nCD-DCs on POD 7, and 3.9 times higher on CD-DCs than on DCs from control livers (Fig. 3B ). These differences were maintained on POD 14 and 30. Costimulatory molecules (CD80, CD86) were expressed at similar levels (mean fluorescence intensity [MFI]) to DCs from control livers, whereas nCD-DCs showed significantly lower CD80 and CD86 expression levels than on CD-DCs on POD 7 (Fig. 3B) . Interestingly, although the number of CD-DCs in the spleen was much less than that of graft CD-DCs, a small percentage (1%-2%) of host spleen DCs was cross-dressed as long as POD 300 and expressed high PD-L1 (Supporting Fig. S1 ). Intracellular cytokine staining revealed that CD-DCs in the graft on POD 7 comprised much higher incidences of IL-10
1 and IL-6 control na€ ıve liver DCs, but a higher incidence than nCD-DCs ( Fig. 3C and 3D ). Taken together, although IL-6 production by CD-DC was also high, graft-infiltrating CD-DCs expressed higher levels of PD-L1 and IL-10 than nCD-DCs, suggesting a regulatory function of these cells. Results (mean 1 SEM) are from n 5 3 graft recipients/group. **P < 0.01; ***P < 0.001. P values were generated by one-way ANOVA followed by a Tukey-Kramer multiple comparisons test.
CD-DCs EXPRESS PD-L1 UNIFORMLY ON THEIR CELL SURFACE
Next, we addressed whether PD-L1 on recipient CD-DC was transferred from donor cells by ascertaining whether PD-L1 colocalized with donor MHC class I molecules on CD-DCs on POD 7 (Fig. 4) . Both confocal microscopy ( Fig. 4A ) and flow imaging (Fig. 4B) demonstrated that, in addition to inherent cell surface recipient H-2D k expression, CD-DCs exhibited acquired donor H-2K b to varying degrees, with most CD-DCs showing punctate donor MHC class I expression on their cell surface. Interestingly, PD-L1 was expressed uniformly on the cell surface of CD-DCs, suggesting that the elevated PD-L1 expression observed on these cells was not due to transfer of PD-L1 from donor cells.
LIVER GRAFT CD-DCs MARKEDLY SUPPRESS DONOR-REACTIVE HOST T CELL PROLIFERATION
We then investigated the allostimulatory function of the CD-DCs. CD-DCs and nCD-DCs were flowsorted from host (C3H) spleen and liver grafts (POD 7), and their ability to directly stimulate na€ ıve allogenic T cells (B6) was assessed ( Fig. 5A and 5B). As shown in Figure 5B and 5C, CD-DCs from both host spleens and liver grafts were impaired in their ability to directly activate/induce proliferation of na€ ıve CD4 and CD8 T cells compared with nCD-DCs and splenic DCs from na€ ıve C3H mice. Both liver CD-DCs (especially) and nCD-DCs showed inferior ability to stimulate na€ ıve T cells compared with splenic DCs from na€ ıve mice. We also found that host spleen and liver graft CD-DCs that expressed donor MHC on their surface failed to prime na€ ıve C3H T cells in vitro (semidirect allo-recognition) (Supporting Fig. S2) .
We also assessed the ex vivo suppressive function of DCs from liver transplant recipients. CD-DCs and nCD-DCs sorted from the graft or spleen on POD 7 were added to na€ ıve C3H responder T cells and allogeneic stimulators (DCs from na€ ıve B6 spleen). Both CD-DCs and nCD-DCs from the graft significantly suppressed the proliferation of CD4 T cells (Fig. 5D and 5E), whereas splenic DC (both CDs and nCDDCs) showed minimal suppressor function. In addition, only liver graft CD-DCs significantly suppressed the proliferation of na€ ıve CD8 T cells (Fig. 5D and  5E) . Notably, the presence of graft CD-DCs significantly increased the death of both CD4 and CD8 T cells (Fig. 5D and 5E ) in both proliferating and nonproliferating populations (Fig. 5D) . Overall, these data demonstrate both impairment of recipient CD-DC T cell priming ability and a suppressor function that is associated with T cell death.
LIVER GRAFT-INFILTRATING T CELLS EXHIBIT AN EXHAUSTED PHENOTYPE
Given the suppressive function of host DCs after liver transplantation, we assessed the phenotype of T cells in the spleen and graft at various times posttransplantation. By POD 7, nearly all of the intragraft T cells exhibited an activated effector/memory phenotype (i.e., CD44 hi CD62L lo ), that persisted up to 300 days posttransplantation ( Fig. 6A and 6B ). Importantly, a significant fraction of the CD4 T cells and nearly all of the CD8 T cells infiltrating the grafts on POD 7 exhibited an exhausted phenotype (PD-1 (Fig. 6C  and 6D) . A concomitant increase in effector/memory T cell differentiation in host spleens was also observed (Fig. 6A and 6B ), but a much lower fraction of splenic T cells demonstrated an exhausted phenotype compared with graft T cells (Fig. 6C and 6D ). Nevertheless, a significantly higher level of CD8 1 T cells (almost 15%-20% of PD-1 1 cells) in host spleens were exhausted compared with that in na€ ıve spleen.
Interestingly, a lower incidence of CD8 1 T cells in the graft on POD 7 produced IL-2, TNFa ( Fig. 6E  and 6F) , and IL-6 (data not shown) than those in normal liver, but the former were predominantly IFNc producers ( Fig. 6E and 6F) , suggesting that the graft CD8 1 T cells were partially exhausted (38) and undergoing functional impairment. Taken together, these data suggest that while some T cells, particularly CD8, become exhausted in the spleen, most T cells become exhausted once they migrate to the liver allograft. In support of this, when graft-infiltrating T cells were stimulated with donor DCs ex vivo, they failed to proliferate and died (Supporting Fig. S3 ).
LIVER GRAFT CD-DCs EXHIBIT DIFFERENT GENE EXPRESSION PROFILES COMPARED WITH nCD-DCs
Given the differences in coregulatory molecule expression and suppressor function between CD-DCs 
FIG. 5. Liver graft CD-DCs fail to stimulate na€ ıve donor T cells and markedly suppress donor-reactive host T cell proliferation. (A)
Protocol for assessing CD-DC and nCD-DC stimulatory and regulatory function in carboxyfluorescein succinimidyl ester mixed leukocyte reaction (CFSE-MLR). B6 livers were transplanted into C3H recipients that were euthanized on POD 7. . Data were obtained from n 5 3 independent experiments. *P < 0.05; **P < 0.01. P values were generated by one-way ANOVA followed by a Tukey-Kramer multiple comparisons test. and nCD-DCs isolated from liver grafts, we next assessed their gene expression profiles. RNA from sort-purified freshly isolated liver graft CD-DCs and nCD-DCs (POD 7) was analyzed using a Nanostring Mouse Immunology Panel. In the heat map generated using nSolver software, approximately 86% of genes showed clear cluster segregation (Fig. 7A) . Notably, PD-L1 gene expression was clearly up-regulated in ) on POD 7 compared with normal C3H control T cells (n 5 3 mice per group). (F) Compilation of data from panel E. Results are presented as the mean 1 SEM percent positive cells (n 5 3 mice per group). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. P values were generated by one-way ANOVA followed by a Tukey-Kramer multiple comparisons test.
liver graft CD-DCs compared with nCD-DCs. CD80 and CD86 gene expression was up-regulated in CDDCs compared with nCD-DCs, which is also consistent with cell surface protein expression (Fig. 3) . Interestingly, both DAP12, which we have shown negatively regulates liver DC stimulatory function, (26, 27) and triggering receptor expressed on myeloid cells 2 (TREM2) (a key DAP12-associated cell surface membrane receptor) (39) were up-regulated in CD-DCs compared with nCD-DCs, suggesting their regulatory function. (40, 41) Because the TREM2-DAP12 pathway in DCs is associated mainly with inhibitory signals, (41) this is consistent with our finding that liver graft CD-DCs are more regulatory than nCD-DCs. Canonical pathways that were either activated or inactivated in liver graft CD-DCs in comparison with nCD-DCs were analyzed using Ingenuity Pathway Analysis software (Fig. 7B) . In the top 10 most significant canonical pathways, dendritic cell maturation, TREM-DAP12 signaling, and Toll-like receptor signaling were activated in CD-DCs, suggesting that these cells were more mature than nCD-DCs. Conversely, pathways inactivated in liver graft CD-DCs were related mainly to T cell activation, consistent with CD-DCs being less stimulatory compared with First, the color of the bar indicates predicted pathway activation (orange) or predicted inhibition (blue) in CD-DCs compared with nCD-DCs, according to the z-score, which is used to compare the dataset with the canonical pathway patterns mathematically. White bars are those with a z-score at or very close to 0. Second, the width of each bar denotes the 2log of the P value, which is calculated by a right-tailed Fisher's exact test and is shown at the top of the x-axis; thus, wider bars equate to increased significance. Third, the interconnected orange points represent the ratio that is calculated as follows: number of genes in a given pathway divided by the total number of genes that make up that pathway based on the previous literature.
nCD-DCs. Overall, gene expression analysis revealed that liver graft CD-DCs and nCD-DCs were differentially activated and that liver graft CD-DCs were characterized by regulatory signaling pathways to a greater extent than graft nCD-DCs.
GRAFT-INFILTRATING DCs IN REJECTING (DAP12 2/2 ) LIVER ALLOGRAFTS EXHIBIT FEWER CD-DCs THAT EXPRESS LESS DONOR MHC CLASS I AND PD-L1 THAN THOSE IN TOLERATED WILD-TYPE GRAFTS
To determine whether cross-dressing of recipient DCs could be observed in rejecting liver allografts, wild-type (WT) (tolerated) or DAP12 2/2 livers that are rejected acutely (27) were transplanted to C3H recipients. We have shown previously (27) that DAP12 grafts on POD 7, we found that they had significantly fewer host CD-DCs than tolerated WT grafts (POD 7; Fig. 8A ). Furthermore, expression of donor MHC class I (H-2K b ) was reduced significantly on total liver DCs and on CD-DCs isolated from DAP12 2/2 grafts on POD 7 ( Fig. 8B and C) . Moreover, the CD-DCs in DAP12
2/2 grafts expressed significantly lower levels of PD-L1 than those in WT grafts (Fig. 8D) . The total number of host DCs infiltrating the graft was also decreased in this model (data not shown). Because we have shown (42) that high PD-L1/CD86 ratios on circulating plasmacytoid DCs correlate with transplant tolerance in human liver transplantation, it is of interest that PD-L1/CD86 ratios on DC infiltrating DAP12 2/2 liver grafts were significantly lower than on those infiltrating WT liver grafts (Fig. 8E ).
Discussion
In this study, we focused on the role of host and in particular, graft-infiltrating recipient DCs in liver transplant tolerance. We found large numbers of recipient-derived CD-DCs within the allografts during the first few days posttransplantation. These CDDCs were PD-L1 hi , were less allostimulatory than nCD-DCs, suppressed antidonor host T cell proliferation, and promoted the death of alloreactive T cells.
The phenomenon of plasma membrane fragment transfer between leukocytes has been reported since 1999 (43) and is called "trogocytosis," "nibbling," or "cross-dressing." It has been postulated that molecules acquired by acceptor APCs during this process influence the outcome of the subsequent T cell response. Recently, several publications (29) (30) (31) have drawn attention to an important role of CD-DCs in the rejection of experimental heart, kidney, and skin transplants. However, here we reveal that, conversely, CD-DCs in liver allografts that are accepted indefinitely without use of immunosuppressive agents, suppress alloreactive T cell responses rather than promote graft rejection.
Liver allografts are distinct from other types of organ transplants in several other regards. Thus, in addition to the liver's hematopoietic and regenerative capacity, liver mesenchymal cells produce/release relatively large amounts of donor intact MHC class I molecules (44) that may be acquired by host-derived DCs infiltrating liver allografts via cross-dressing. Indeed, most liver cell types, including hepatocytes, cholangiocytes, LSECs, stellate cells, and immune cell populations produce extracellular vesicles that express MHC gene products under in vitro conditions. (45) Moreover, liver allografts are also enriched in PD-L1 (33, 46) that may confer high PD-L1 expression on graft-infiltrating host DCs. By analogy, in cancer, it is evident that tumor-associated PD-L1, that promotes T cell apoptosis, impairs DC-mediated antitumor immunity. (47) When we examined cross-dressed cells by flow imaging and confocal microscopy, we found that CDDCs uniformly expressed recipient MHC class I molecules on the cell surface, but only expressed donor MHC class I in localized spots, indicating that these cells were DCs of recipient origin and cross-dressed with donor MHC molecules. Importantly, PD-L1 was expressed uniformly on the cell surface of CD-DCs, consistent with its up-regulation at the messenger RNA level. However, the mechanism by which CDDCs expressed relatively high amounts of PD-L1 messenger RNA and protein remains unknown. One possibility is that, regardless of cross-dressing, these DCs are activated by various cytokines to gain the ability to acquire donor MHC molecules and that acquisition of intact donor MHC class I molecules may alter the phenotype and function of the graft-infiltrating DCs.
The cell coculture experiments that we conducted to ascertain which hepatic donor cell populations served as the source of MHC class I for host CD-DCs revealed that hepatocytes were the principal source, whereas only very low levels of DCs were cross-dressed with donor MHC class I from LSECs or stellate cells. Marked reduction in the incidence of DCs that expressed hepatocyte-derived donor MHC class I when transwells were present indicated that physical contact was required for cross-dressing. This finding may reflect a lack of migration of extracellular vesicles grafts were significantly lower (27% 6 4%) on POD 7 compared with WT grafts (60% 6 8%; n 5 3-5 mice per time point in each group). *P < 0.05; **P < 0.01. (B) Expression of donor MHC class I (H-2K b ) (MFI) on WT and DAP12 2/2 liver graft total DCs (left) and CD-DCs (right) on POD 7 and 14 *P < 0.05. (C) Expression of coinhibitory and costimulatory molecules (MFI) by CDDCs and nCD-DCs in DAP12 2/2 or WT grafts determined by flow cytometry on POD 7 (n 5 3-5 mice per time point in each group). *P < 0.05; **P < 0.01; ***P < 0.001. (D) Ratio of PD-L1 to CD86 expression by liver graft DCs on POD 7 determined on the basis of MFI. Data are presented as the mean 1 SEM (n 5 3-5 mice in each group). *P < 0.05. P values were generated by oneway ANOVA followed by a Tukey-Kramer multiple comparisons test. from the donor hepatocytes through the transwell, as described recently (29) in relation to MHC transfer between allogeneic donor and acceptor DC populations.
An important finding in this study is that CD-DCs that infiltrate liver allografts exhibit little T cell allostimulatory function but can markedly suppress host alloreactive T cell responses. This regulatory function may be a consequence of high PD-L1 expression by the CD-DCs. Indeed, we found that a large number of T cells in the liver allografts were effector memory cells, and that most of them expressed high levels of the exhaustion markers PD-1 and TIM-3. These graftinfiltrating T cells exhibited less proliferative capacity in carboxyfluorescein succinimidyl ester mixed leukocyte reaction, even in the presence of potent allostimulatory APCs, and underwent apoptotic cell death, as we observed previously in tolerated mouse liver allografts. (48) High IL-10 secretion by liver graft CD-DCs also supports their immune regulatory function. Because the level of IL-10 gene expression by CD-DCs and nCD-DCs was similar, this suggests that these two populations behave differently after stimulation. In the liver graft rejection model (DAP12 2/2 grafts), both the percentage and absolute number of CD-DCs were less than those detected in tolerated liver allografts, and their surface expression of PD-L1 was significantly lower, again suggesting that these graft-infiltrating CD-DCs and their expression of PD-L1 may be important in the induction of liver transplant tolerance.
PD-L1 expression is up-regulated in liver grafts after transplantation in both mice and humans, and the PD-L1-PD-1 pathway has been implicated in regulation of anti-donor immunity. (49) Moreover, Morita et al. (46) have reported that mesenchyme-mediated immune control, in particular PD-L1 expression by the graft, is important for the development of mouse liver transplant tolerance. Thus, they showed that blocking of the PD-1-PD-L1 pathway or transplantation of PD-L1
2/2 grafts led to pronounced leukocyte infiltration and abrogation of transplant tolerance. In this study, we focused on intragraft DCs rather than liver mesenchymal cells, because of evidence that liver DCs can subvert T cell responses (13, 24) and promote allograft survival. (21, 22) Indeed, we found that cell surface PD-L1 expression by CD-DCs was several-fold higher than that detected on nCD-DCs on POD 7, and that this effect correlated with suppression of host antidonor T cell proliferation. In a previous report, (50) activated hepatic stellate cells expressing PD-L1 hi were found to suppress activated T cells by promoting their apoptosis, but failed to inhibit or regulate their proliferation. This finding suggests that liver-resident cells expressing PD-L1
hi have a regulatory function in situ but may lack the ability to regulate systemic T cell activation. Considering that after liver transplantation, subsequent skin or heart allografts from the same donor strain are accepted spontaneously, (1) local and systemic T cell regulation appears to occur after liver transplantation; CD-DCs, therefore, may regulate antidonor T cell responses in the periphery or in secondary lymphoid tissue. The data we present in this study (see Fig. 6 ) indicate that, in WT liver allograft recipients, host T cells respond normally to donor allo-antigen in the spleen, but that once they migrate to the liver, they gain TIM-3/PD1 expression, suggesting that the tolerogenic effect may be localized to the liver.
We propose a concept to help explain the induction/ maintenance of liver transplant tolerance. Thus, graftinfiltrating PD-L1 hi host DCs may serve to subvert antidonor T cell responses and promote exhaustion and/or death of graft-infiltrating CD8
1 T cells and, as a result, promote transplant tolerance. Because after liver allotransplantation, the peak of CD-DCs in the graft is on POD 7 and that of infiltrating T cells (especially CD8
1 T cells) is on POD 14, the fate of the graft may be determined within the first 2 weeks of transplantation. Elucidation of mechanisms whereby immunoregulatory CD-DCs arise in the graft may provide future directions toward the promotion of transplant tolerance in the clinic.
In conclusion, a large proportion of host-derived CD-DCs expressing high levels of PD-L1 and IL-10, and with the capacity to subvert antidonor host T cell responses, are evident in MHC mismatched mouse liver allografts early posttransplantation. These CD-DCs may play a key role in the regulation of alloimmunity and in the promotion of liver transplant tolerance.
